## Resumo executivo

Alternative ex-ante family gate result: `FAIL/abandon`. Classification: `ALTERNATIVE_EXANTE_FAMILIES_NO_POSITIVE_SAFE_MEDIAN_ALPHA`.

## Baseline congelado

Branch `codex/autonomous-sniper-implementation`, commit `25bae6e303ae6dda297fff7830915c8a1355b405`. The gate tests research/sandbox portfolios only.

## Mudanças implementadas

## Artifacts gerados

- `reports\gates\phase5_research_alternative_exante_family_gate\alternative_exante_family_positions.parquet`
- `reports\gates\phase5_research_alternative_exante_family_gate\alternative_exante_family_daily_returns.parquet`
- `reports\gates\phase5_research_alternative_exante_family_gate\alternative_exante_family_trade_log.parquet`
- `reports\gates\phase5_research_alternative_exante_family_gate\alternative_exante_family_metrics.parquet`
- `reports\gates\phase5_research_alternative_exante_family_gate\alternative_exante_family_snapshot_proxy.parquet`
- `reports\gates\phase5_research_alternative_exante_family_gate\portfolio_cvar_research_report.json`
- `gate_report.json`
- `gate_report.md`
- `gate_manifest.json`
- `gate_metrics.parquet`

## Resultados

Best policy `ensemble_top3` from `regime_filtered_defensive_ensemble` had median combo Sharpe `-0.632456`, min combo Sharpe `-2.11257`, median active days `14.0`, and max CVaR95 loss `0.01727292`.

## Avaliação contra gates

## Riscos residuais

DSR remains 0.0, official CVaR remains zero exposure, and cross-sectional remains not promotable.

## Veredito final: advance / correct / abandon

`abandon`. Continue only with a bounded research correction or final family comparison.
